Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma…
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent…
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Finance
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows…
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:ATOS
Tag: NASDAQ:ATOS
Atossa Therapeutics Inc (NASDAQ:ATOS) Commences Treatment Of A Patient With Ovarian...
Gavins Felicity
-
May 3, 2021
0
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Interim Results From Phase 2...
Kate Hudson
-
April 12, 2021
0
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Tolerability And Safety Of AT-301 In...
Matt Wade
-
March 10, 2021
0
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Outcome In A Two-Year Treatment...
Kate Hudson
-
February 26, 2021
0
The Clinical Study of AT-301 Nasal Spray in the First Group...
Kate Hudson
-
September 15, 2020
0
1
2
3
Page 2 of 3
Recent Post
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows...
Kate Hudson
-
May 8, 2024
0
Actinium Pharmaceuticals (ATNM) shares saw slight volatility on Tuesday, closing at $8.81 (-0.34%). However, recent announcements concerning the company's Iomab-ACT project could...
Actinium Pharmaceuticals (ATNM) Gains Momentum: Strategic KOL Call Scheduled Amid Radiopharma...
May 7, 2024
Reason why Investors need to watch Aspen Aerogels (NYSE: ASPN) recent...
May 2, 2024
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
May 1, 2024
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing...
May 1, 2024